CorMedix CEO Joseph Todisco receives $2.7M in 2022
CorMedix reports 2022 executive compensation
By ExecPay News
Published: September 13, 2023
CorMedix reported fiscal year 2022 executive compensation information on September 13, 2023.
In 2022, five CorMedix executives received on average a compensation package of $1.3M, a 17% decrease compared to previous year.
Average pay of disclosed executives at CorMedix
Joseph Todisco, Chief Executive Officer, received $2.7M in total. 47% of Todisco's compensation, or $1.3M, was in option awards. Todisco also received $306K in non-equity incentive plan, $378K in salary, $701K in stock awards, as well as $32K in other compensation.
Matthew David, Chief Financial Officer, received a compensation package of $1.1M, which decreased by 20% compared to previous year. 35% of the compensation package, or $393K, was in salary.
Phoebe Mounts, General Counsel, earned $1M in 2022, a 37% decrease compared to previous year.
Thomas Nusbickel, Former Chief Commercial Officer, received $946K in 2022, which decreases by 50% compared to 2021.
Elizabeth Hurlburt, Executive Vice President and Head of Clinical Operations, earned $845K in 2022, a 26% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on September 13, 2023.